Aytu Biopharma (AYTU) Total Debt: 2009-2025
Historic Total Debt for Aytu Biopharma (AYTU) over the last 14 years, with Sep 2025 value amounting to $25.3 million.
- Aytu Biopharma's Total Debt rose 72.24% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.8 million, marking a year-over-year increase of 33.37%. This contributed to the annual value of $20.0 million for FY2025, which is 50.38% up from last year.
- Latest data reveals that Aytu Biopharma reported Total Debt of $25.3 million as of Q3 2025, which was up 26.87% from $20.0 million recorded in Q2 2025.
- In the past 5 years, Aytu Biopharma's Total Debt registered a high of $25.3 million during Q3 2025, and its lowest value of $13.3 million during Q2 2024.
- Its 3-year average for Total Debt is $17.5 million, with a median of $16.1 million in 2023.
- Its Total Debt has fluctuated over the past 5 years, first spiked by 1,615.68% in 2021, then crashed by 30.54% in 2024.
- Quarterly analysis of 5 years shows Aytu Biopharma's Total Debt stood at $16.5 million in 2021, then surged by 33.33% to $22.0 million in 2022, then fell by 27.13% to $16.0 million in 2023, then dropped by 12.55% to $14.0 million in 2024, then skyrocketed by 72.24% to $25.3 million in 2025.
- Its Total Debt stands at $25.3 million for Q3 2025, versus $20.0 million for Q2 2025 and $19.6 million for Q1 2025.